<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

‘Pivotal’ Time for DLBCL Treatment Options

by Cure Today | September 7, 2023
placeholder

“I do believe things are looking really good for patients with DLBCL,” Manali Kamdar, a clinical researcher in the field of blood cancers at the University of Colorado Anschutz Medical Campus, tells us.

Topics: Press Coverage